StockpollyBeta
Get App
Delisting riskPopularity #4,127
LEXX · NASDAQ · Biotechnology

Lexaria Bioscience (LEXX)

Developer and licensor of DehydraTECH oral drug-delivery technology.

$3.36
After hours+0.17 (+5.33%)
At close$3.19(−6.86%)

In millions of USD, except per-share figures

In millionsQ4 FY23Aug 2023Q1 FY24Nov 2023Q2 FY24Feb 2024Q3 FY24May 2024Q4 FY24Aug 2024Q1 FY25Nov 2024Q2 FY25Feb 2025Q3 FY25May 2025Q4 FY25Aug 2025Q1 FY26Nov 2025Q2 FY26Feb 2026Q3 FY26May 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
111223343212
Research & development110112232101
111111111111
General & administrative111111111111
Operating income−1−1−1−2−2−3−3−4−3−2−1−2
000000000000
Interest income000000000000
Other non-operating income000000000000
Income before tax−1−1−1−2−2−3−3−4−3−2−1−2
Income tax expense000000000000
Net income from continuing operations−1−1−1−2−2−3−3−4−3−2−1−2
Net income−1−1−1−2−2−3−3−4−3−2−1−2
EPS, basic−$1.80−$1.95−$0.90−$1.95−$2.55−$2.40−$2.25−$3.15−$2.10−$1.12−$0.90−$1.20
EPS, diluted−$1.80−$1.95−$0.90−$1.95−$2.55−$2.40−$2.25−$3.15−$2.10−$1.12−$0.90−$1.20
Weighted average shares, basic011111111122
Weighted average shares, diluted011111111122
EBITDA−1−1−1−2−2−3−3−4−3−2−1−2
Depreciation & amortization000000000000
EBIT−1−1−1−2−2−3−3−4−3−2−1−2